🇮🇳India
कैटेगरी I ड्रग्स पर 90% बजट व्यय
1 verified sources
Definition
High expenditure on critical drugs without tight control causes budget overruns.
Key Findings
- Financial Impact: 90% budget on 47.88% Category I drugs[4]
- Frequency: Annual consumption
- Root Cause: Inadequate ABC-VED implementation
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Hospitals.
Affected Stakeholders
Medical Store Managers
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Evidence Sources:
Related Business Risks
इन्वेंटरी संकोचन और समाप्ति हानि
Hefty penalties for non-compliance + waste from expired stock (typical 5-10% annual inventory loss)[2]
मैनुअल ऑडिट से परिचालन अक्षमता
20-40 hours/month staff time on manual audits and inefficiencies[2]
फार्मास्युटिकल इन्वेंटरी में बफर स्टॉक अतिरेक
₹98,000.54 average daily expenditure (73.82%) on Category I drugs with low buffer needs; substantial savings by removing Category III items[1]
ओवरस्टॉकिंग से कार्यशील पूंजी बंधन
Ties up working capital; lost sales from stockouts + waste from expiries (industry typical 2-5% inventory value)[2]
रिजेक्शन मैनुअल वर्क
40-60 hours/month at ₹500/hour = ₹20,000-30,000/month
बॉटलनेक क्लीयरिंगहाउस
24-48 hours delay per batch = 5-10% capacity loss